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Highly specific antibodies to cytochrome P-450~ and its F~ and F 2 fragments, representing N- and C-terminal sequences 
of the hemeprotein respectively, were raised in rabbits. These antibodies were found to be inhibitory (up to 50-90%) for 
the cholesterol transformation into pregnenolone in the reconstituted system, indicating the involvement of both F 1 and 
F 2 domains formed by the respective fragments in monooxygenase catalysis. Cytoehrome P-450~¢ in mitoplasts i  not 
accessible for trypsin as revealed by immunological techniques. However, the treatment of submitochondrial particles 
with trypsin results in two main fragments identified by immunoblotting in the presence of the monospecific antibodies 
as F~ and F 2 fragments. This indicates that the trypsin sensitive 250-257 region in cytochrome P-450~ molecule connect- 
ing both domains is exposed to the matrix side of the inner mitochondrial membrane. 
Cytochrome P-450~ domain; Membrane organization; Monospecific antibody; Monooxygenase catalysis; Inhibition; (Bovine adrenal 
cortex) 
1. INTRODUCTION 
At least two cytochrome P-450-dependent 
systems are localized in the inner membrane of 
adrenocortical mitochondria: cholesterol side 
chain cleavage (scc) and l lb-hydroxylating ones 
[1]. Both P-450scc and P-45011b receive two elec- 
trons from NADPH via adrenodoxin reductase 
and adrenodoxin. 
Limited proteolysis of the native purified 
P-450~¢¢ with trypsin results in two large fragments: 
F1 with molecular weight of 29 800 Da and F2 of 
26 600 Da [2], corresponding to N- and C-terminal 
sequences of the hemeprotein, respectively (fig. 1). 
These fragments appear to form domains differing 
in their functional properties [3,4]. The aim of the 
present work is to prepare monospecific antibodies 
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to P-450scc and its structural fragments F~, F2 and 
F3 (N-terminal sequence of F2), and to use these an- 
tibodies in: (i) investigation f the role of structural 
elements in cholesterol conversion; (ii) study of 
P-450scc organization i membrane in comparison 
with purified protein. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
NADPH, glucose-6-phosphate, glucose-6-phosphate d - 
hydrogenase were purchased from Boehringer (Wien, Austria). 
[3H]Cholesterol (58 Ci/mmol) was from Amersham Interna- 
tional (Amersham, England). Complete Freund's adjuvant was 
from Calbiochem (La J011a, CA, USA). Other chemicals were 
purchased from Serva (Heidelberg, FRG). 
2.2. Purification and proteolysis procedures 
P-450 .... adrenodoxin and adrenodoxin reductase were 
isolated from bovine adrenocortical mitochondria as described 
[5]. Membrane-bound P-450sc¢ preparates were isolated by 
treatment of the native mitochondria with digitonin (for 
preparation of mitoplasts) [4] following the sonication of mito- 
plasts (for SMP preparation) with subsequent washing of the 
SMP with 50 mM PB, pH 7.4, containing 0.2 M NaCl [6]. Pro- 
teolysis was done in the same buffer at the trypsin/P-450scc ratio 
1:25. Then suspension of SMP was diluted 1 : 10 and centrifug- 
ed. The pellet was resuspended in 1 ml buffer and the superna- 
tant was concentrated to the same volume for SDS-PAGE 
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Fig.1. The main pathways of P-450s¢¢ trypsinolysis. Arrows 
show the sites in the P-450,¢¢ polypeptide chain accessible to 
trypsin. 
samples preparation [4]. Trypsinolysis of purified P-450scc and 
separation ofF~, F2 and F3 were carried out as described in [2]. 
P-450scc oncentration was determined as in [7]. 
2.3. lmmunological procedures 
100/~g of P-450scc, F2 or F3 or 200/zg of Ft in 0.35 ml of 
50 mM PB, pH 7.4, containing 0.1207o SDS, were mixed with 
equal volume of Freund's complete adjuvant and injected in 
several places in the neck of rabbits. This treatment was given 
intracutaneously during 6 weeks every other week. Blood 
samples taken from the marginal ear vein at 8 days after the last 
immunization were used for preparation of the antisera. Im- 
munoblotting was performed as described in detail in [4]. 
2.4. Assay of P-45Oscc activity 
The catalytic activity in reconstituted system in the presence 
of antibodies was examined as previously described [7]. P-450scc 
was preliminarily incubated with the antibodies for 10 min at 
20°C. The reaction was initiated by addition of a NADPH- 
regenerating system containing 0.4 mM NADPH, 2.5 mM 
glucose-6-phosphate nd 2 U/ml of glucose-6-phosphate de- 
hydrogenase. 
3. RESULTS 
3.1. Antigenic properties ofF1 and F2 
Ant ibodies to P-450s¢¢ interact with hemepro-  
tein, F1, F2 and F3 as revealed by dif ferent im- 
munological  procedures including immunoblot t ing 
[4]. The f inding that the structural elements of  
P-450scc retain antigenic propert ies became a prere- 
quisite for further p reparat ion  o f  ant ibodies 
against these fragments. The ant ibodies obtained 
were shown to interact with P-450~¢~ and cor- 
responding antigens but they do not cross-react, as 
demonstrated by the same method (fig.2). 
3.2. Effect of the antibodies on P-450sc~- 
dependent cholesterol transformation 
Ant ibodies against P-450s~¢ and its fragments 
proved to be potent inhibitors of  the reaction 
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Fig.2. Immunoblotting of P-450s¢c and their fragments. (A) 
SDS-PAGE (12.5°70) of the purified antigens. The samples con- 
tained: 1, P-450scc + F1 + F2; 2, P-450sce; 3,FI; 4, F2. The gel 
was stained with Coomassie R-250. The blots B, C and D were 
treated with signed antisera diluted 1:200 and then these were 
stained by the peroxidase method [4]. 
catalyzed by the hemeprotein (fig.3). At  the highest 
rat ios o f  antibodies,  the activity was inhibited by 
more than 80°7o. General ly,  there was less inhibi- 
t ion of  cholesterol metabol ism by ant ibodies to F2 
and F3 than when ant ibodies to F1 were used. None 
o f  the ant ibodies used were able to inhibit choles- 
terol conversion into pregnenolone completely. 
The residual activity at the highest concentrat ion of  
ant ibodies against P-450~c¢ and its fragments might 
result f rom P-450~cc molecules that are not accessi- 
ble to ant ibodies ince hemeprotein is in aggregated 
state [5]. 
3.3. Proteolysis of membrane-bound P-450scc 
To compare the molecular  organizat ion of  
pur i f ied and membrane-bound P-450scc we carried 
out the treatment of  mitoplasts and SMP with tryp- 
sin. The products of  trypsinolysis were detected by 
immunoblot t ing  with ant ibodies against P-450sc¢, 
F1 and F2. As fol lows from fig.4, membrane-  
bound P-450s¢¢ is subjected to l imited proteolysis 
only in SMP.  This conclusion is based on the fact 
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Fig.3. P-450sc~ activity in the presence of the antibodies. The 
samples contained increasing amounts of the following antisera: 
1, anti-P-450scc; 2, anti-F~; 3, anti-F2; 4, anti-F3, The re- 
constituted system contained 1 nmol of P-450~¢~, 1 nmol of 
adrenodoxin reductase and 5 nmol of adrenodoxin. Cholesterol 
concentration was 50/~M. The activity without any antiserum 
(20.1% of cholesterol transformation i to pregnenolone) was 
taken as 100%. *, Activity in the presence ofnon-immune rab- 
bit antiserum. 
that the antibodies recognize two main proteolytic 
products which are identical with F1 and F2 of 
purified P-450~¢¢ according to their molecular 
weights and immunological properties. The treat- 
ment does not result in elimination of any P-450~¢¢ 
products from membrane. It seems that region 
250-257 in P-450~ molecule is exposed to matrix 
and both Ft and F2 are rigidly associated with 
membrane. 
Moreover, some differences in proteolysis of 
purified and membrane-bound P-450~¢¢ appear to 
exist. In contrast o purified P-450scc, during initial 
time of proteolysis of SMP a protein band with 
molecular mass of about 45 000 Da is recognized 
by all types of antibodies. This band appears to 
correspond to Fo (fig.l) which is formed during 
trypsinolysis of pH-denatured or tetranitro- 
methane-treated P-450~¢¢ [4]. Finally, we detected 
in untreated SMP an additional P-450sc¢ band with 
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Fig.4. Trypsinolysis of membrane-bound P-450 .... (A) SDS- 
PAGE (10%); (B, C and D) immunobloning with signed anti- 
sera diluted 1:200. The samples (0.01 ml) contained: 1,purified 
P-450s¢¢ + trypsin (100: 1, 20 min); 2, mitoplasts + trypsin 
(25 : 5 : 1, 80 min), supernatant + pellet; 3 and 4, SMP + tryp- 
sin (25 : 1, 20 rain), supernatant and pellet, respectively; 5 and 6, 
SMP + trypsin (25" 1, 80 min), supernatant and pellet. 
higher molecular weight than native P-450~¢¢, 
which seems to correspond to a precursor of the 
hemeprotein [8]. 
4. DISCUSSION 
Preparation of monospecific antibodies against 
functionally formed structural elements of P-450sc¢ 
indicates that antigenic determinants are widely 
distributed in the polypeptide chain of the heme- 
protein. This is a rather unique situation when 
polyclonal antibodies could be prepared against 
polypeptides carrying definite functional proper- 
ties. The fact that antibodies against P-450s¢¢ and 
its fragments are inhibitors of cholesterol conver- 
sion into pregnenolone indicates that both P-450s¢~ 
functional domains formed by F1 and F2 par- 
ticipate in monooxygenase catalysis. 
Trypsinolysis of SMP confirms the similarity of 
the molecular organization of purified and 
membrane-bound P-450~c. The results obtained in 
the present work also demonstrate that different 
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parts of  P-450scc polypept ide chain are closely 
associated and interact during monooxygenase 
catalysis. This is in contrast o the simple model  for 
P-450scc organizat ion in phosphol ip id  membrane 
according to which hemeprotein consists of  two in- 
dependent  domains,  a hydrophi l ic  region that 
bears the heme group and a funct ional ly distinct 
hydrophobic  domain  that anchors the molecule to 
membrane as in the cases of  cytochrome b5 [9] and 
cytochrome P-450 reductase [10]. 
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